English | Español
Jamie Barrand | Oct 1, 2015

Mylan introduces generic Paliperidone in U.S.
Jamie Barrand | Sep 30, 2015

FDA requirements changing for prescribing and dispensing Clozapine
Jamie Barrand | Sep 29, 2015

Nasal spray may be effective epilepsy seizure treatment
Jamie Barrand | Sep 29, 2015

NIH offers tips to keep diabetic children safe during school year
Jamie Barrand | Sep 28, 2015

ViiV Healthcare releases update on HIV therapy
Jamie Barrand | Sep 28, 2015

Webcast of FDA meeting on Huntington's, Parkinson's diseases available
Jamie Barrand | Sep 28, 2015

Merck presenting Keytruda data at European Cancer Congress
Jamie Barrand | Sep 28, 2015

Amgen's Kyprolis to get FDA priority review

Trending
+ Pharmaceuticals
Patient Daily | Nov 13, 2025

Students for Trump Chairman on 340B: ‘78% of 340B benefits go to wealthy hospitals, not patients’
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Political commentator on 340B abuse: 'They're lining pockets, not helping patients'
+ Pharmaceuticals
Patient Daily | Nov 13, 2025

Anesthesiologist on 340B: ‘No clear evidence that 340B hospitals and their contract pharmacies use 340B profits to help lower costs'
+ Pharmaceuticals
Patient Daily | Nov 7, 2025

Bliksem Health founder on 340B reform: 'Health systems buy drugs at steep discounts and pocket the spread'